Mohanad S Awadalla1, Michael Desimone2, Wahid Wassef2. 1. Internal Medicine Residency. 2. Gastroenterology Department, University of Massachusetts Medical Memorial Center, Worcester, Massachusetts, USA.
Abstract
PURPOSE OF REVIEW: Upper gastrointestinal bleeding (UGIB) is a common and life-threatening condition in the United States and worldwide. RECENT FINDINGS: There have been several exciting recent advances in the endoscopic management of UGIB. One such advance is the recent approval of Hemospray by US Food and Drug Administration in May 2018. Another one is the emerging role of video capsule endoscopy as a triage and localization tool for UGIB patients. Finally, the development of new reversal agents for antithrombotic medications is an important advance in the management of life-threatening upper gastrointestinal bleed. SUMMARY: In this article, we will broadly review the management of nonvariceal UGIB, focusing primarily on the data addressing these new advances.
PURPOSE OF REVIEW: Upper gastrointestinal bleeding (UGIB) is a common and life-threatening condition in the United States and worldwide. RECENT FINDINGS: There have been several exciting recent advances in the endoscopic management of UGIB. One such advance is the recent approval of Hemospray by US Food and Drug Administration in May 2018. Another one is the emerging role of video capsule endoscopy as a triage and localization tool for UGIBpatients. Finally, the development of new reversal agents for antithrombotic medications is an important advance in the management of life-threatening upper gastrointestinal bleed. SUMMARY: In this article, we will broadly review the management of nonvariceal UGIB, focusing primarily on the data addressing these new advances.